Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIOT C Study 2: Aromatase inhibitor co-treatment to reduce impact of ovarian stimulation
2017-004433-93Phase 2Completed
- Sponsor
- Nicholas Stephen Macklon
- Start
- Nov 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of letrozole (2 arms), sponsored by Nicholas Stephen Macklon. Primary endpoint: Primary endpoint: luteal phase length. Started Nov 2017; status: completed.
02
Drugs
letrozole
Beyond the preview
Go deeper on 2017-004433-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004433-93.